Literature DB >> 1629212

The all-D-configuration segment containing the IKVAV sequence of laminin A chain has similar activities to the all-L-peptide in vitro and in vivo.

M Nomizu1, A Utani, N Shiraishi, M C Kibbey, Y Yamada, P P Roller.   

Abstract

Laminin is a basement membrane glycoprotein that has diverse biological activities. A sequence on the A chain containing IKVAV (Ile-Lys-Val-Ala-Val) has been shown to promote neurite outgrowth, cell adhesion, and tumor growth and metastasis. Here we have determined the structural requirements of this synthetic peptide for biological activity. Twelve-amino acid-long all-L- (LAM-L) and all-D-peptide (LAM-D) segments as well as an alternating D- and L-amino acid-containing peptide (LAM-DL), which included the IKVAV sequence (residues 2097-2108), were synthesized. Circular dichroism spectral analysis revealed a mirror image conformation of LAM-D and LAM-L with mainly beta-sheet and to a minor extent alpha-helical structure. LAM-DL did not exhibit any significant ordered conformational features. LAM-D and LAM-L showed similar cell attachment activities for rat pheochromocytoma cells (PC12), whereas LAM-DL was inactive. A peptide analog with randomized IKVAV sequence (LAM-RM) was also inactive. A similar trend was observed in competition experiments of the four peptides with laminin in analogous cell attachment assays. In in vivo experiments, both LAM-D and LAM-L were capable of increasing tumor growth when subcutaneously injected into mice with murine melanoma cells B16F10. Results indicate that the conformational status of the IKVAV domain is a contributing factor in determining the biological activity but that there is no strict requirement for a specific chirality. There is a likely sequence specificity to the IKVAV region.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629212

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway.

Authors:  Vanessa M Freitas; Vanessa F Vilas-Boas; Daniel C Pimenta; Vania Loureiro; Maria A Juliano; Márcia R Carvalho; João J V Pinheiro; Antonio C M Camargo; Anselmo S Moriscot; Matthew P Hoffman; Ruy G Jaeger
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

2.  Modification of gelation kinetics in bioactive peptide amphiphiles.

Authors:  Krista L Niece; Catherine Czeisler; Vibhu Sahni; Vicki Tysseling-Mattiace; Eugene T Pashuck; John A Kessler; Samuel I Stupp
Journal:  Biomaterials       Date:  2008-09-06       Impact factor: 12.479

3.  Laminin gamma 1 chain peptide, C-16 (KAFDITYVRLKF), promotes migration, MMP-9 secretion, and pulmonary metastasis of B16-F10 mouse melanoma cells.

Authors:  Y Kuratomi; M Nomizu; K Tanaka; M L Ponce; S Komiyama; H K Kleinman; Y Yamada
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

Review 4.  Laminin-111-derived peptides and cancer.

Authors:  Yamato Kikkawa; Kentaro Hozumi; Fumihiko Katagiri; Motoyoshi Nomizu; Hynda K Kleinman; Jennifer E Koblinski
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

5.  Inhibition of angiogenesis, tumour growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-Ile-Gly-Ser-Arg (YIGSR).

Authors:  Y Iwamoto; M Nomizu; Y Yamada; Y Ito; K Tanaka; Y Sugioka
Journal:  Br J Cancer       Date:  1996-03       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.